Professional Summary

Professional Overview

Mike Crowther is a seasoned biopharmaceutical executive with over 30 years of experience in the industry. As the Chief Commercial and Business Officer (CCBO) at Verastem Oncology, he is responsible for leading the company's global commercial and business development strategies, driving growth and maximizing the impact of Verastem's innovative oncology treatments.

Experience Summary

Current Role

In his current role as CCBO at Verastem Oncology, Mike is instrumental in shaping the company's commercial vision and driving the successful launch and commercialization of its oncology portfolio. He oversees all aspects of the company's global commercial operations, including marketing, sales, market access, and business development. Under his leadership, Verastem has achieved significant milestones in expanding patient access to its therapies and strengthening its competitive position in the oncology market.

Career Progression

Prior to joining Verastem, Mike held various senior leadership positions at prominent biopharmaceutical companies, including Minerva Biotechnologies, Kite Pharma, and Celgene. As the Chief Business Officer at Minerva Biotechnologies, he successfully led the company's strategic and operational initiatives, contributing to its growth and development. At Kite Pharma, he spearheaded the U.S. marketing and training efforts, playing a pivotal role in the successful commercialization of the company's innovative cell therapy products. During his tenure at Celgene, Mike served as the Executive Director of Global Marketing for Lymphoma, where he drove the successful launch and commercialization of several groundbreaking oncology therapies.

Academic Background

Mike holds a Bachelor of Science degree from Manchester Metropolitan University, where he developed a strong foundation in the sciences and laid the groundwork for his distinguished career in the biopharmaceutical industry.

Areas of Expertise

Mike's extensive experience spans a wide range of areas, including:

• Global commercial strategy and execution

• Launch and commercialization of innovative oncology therapies

• Strategic business development and partnerships

• Market access and reimbursement

• Cross-functional team leadership and collaboration

Professional Impact

Throughout his career, Mike has consistently demonstrated a track record of driving commercial success and delivering measurable results. He has played a pivotal role in the successful launch and commercialization of numerous oncology products, contributing to improved patient outcomes and significantly advancing the standard of care in the industry.

Conclusion

With his deep industry expertise, strategic vision, and proven track record of achievement, Mike Crowther is well-positioned to continue driving growth and innovation as the Chief Commercial and Business Officer at Verastem Oncology. His unwavering dedication to improving the lives of patients with cancer and his ability to translate scientific advancements into tangible commercial success make him a valuable asset to the company and the broader biopharmaceutical industry.